Fendosal

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C25H19NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9Z709558TZ, chemically known as 5-(4,5-dihydro-2-phenyl-3h-benz(e)indol-3-yl)salicylic acid but generally known as fendosal, which bears US NIH Compound Identifier 40821. European Medicines Agency schedules Fendosal in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07555MIG. The term FENDOSAL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). FENDOSAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fendosal under HS 29339990 and SITC 51577. As of Q4 2014, FENDOSAL remains the US FDA Preferred Term for this commodity. Fendosal bears US NLM identifiers UMLS ID C0060164 and NCI Concept Code C80549. SMILES: OC1C(CC(N2C3CCC4C(C3CC2C2CCCCC2)CCCC4)CC1)C(=O)O.